Related Experiment Video
Updated: Nov 28, 2025

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
Non-steroidal anti-inflammatory drugs in the environment: Where were we and how far we have come?
Parnian Izadi1, Parin Izadi1, Rana Salem1
1Lassonde School of Engineering, Civil Engineering, York University, 4700 Keele Street, Toronto, M3J 1P3, ON, Canada.
Abstract:
Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most well-known pharmaceuticals with a broad scope of properties that are widely used in human and veterinary medicine. Because of their extensive utilization, NSAIDs are commonly identified in the environment as trace emerging contaminants. Regardless of vast experience with these drugs, NSAIDs are full of contradictions that trigger major concerns for environmental researchers. A limited understanding on NSAID's occurrence, distribution and eco-toxicological effects have led to an escalated dilemma in the last decade. Thus, a broad-spectrum study covering all aspects of occurrence, detection and removal is required to meet the fundamental levels of knowledge on the effects of NSAIDs in all exposed environmental aspects. Therefore, this paper focuses on classifying the sources and entry points of residual NSAIDs. Further, detecting and regulating their concentrations in both input streams and receiving environments, along with the removal processes of this specific class of emerging compounds, in the direction of developing a management policy is comprehensively reviewed.
More Related Videos
07:50Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
Published on: July 16, 2012
05:46Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation
Published on: August 1, 2018
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...